Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Nov;78(2):143–148.

The current status of neutrophil cytoplasmic antibodies.

F J van der Woude 1, M R Daha 1, L A van Es 1
PMCID: PMC1534659  PMID: 12412739

Abstract

Several studies in the past 10 years have demonstrated the occurrence of autoantibodies against cytoplasmic constituents in patients with vasculitis and glomerulonephritis. In this review the nomenclature of these antibodies is discussed and assays and clinical associations are summarized. Although the antigens involved are not completely identified, antibodies and T cells reactive with myeloid lysozomal enzymes may both play a significant role in pathogenesis.

Full text

PDF
143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrassy K., Koderisch J., Waldherr R., Rufer M. Diagnostic significance of anticytoplasmatic antibodies (ACPA/ANCA) in detection of Wegener's granulomatosis and other forms of vasculitis. Nephron. 1988;49(3):257–258. doi: 10.1159/000185068. [DOI] [PubMed] [Google Scholar]
  2. Anti-neutrophil-cytoplasm antibodies in Wegener's granulomatosis are not directed against alkaline phosphatase. Lancet. 1987 Jun 27;1(8548):1488–1490. [PubMed] [Google Scholar]
  3. Borregaard N., Heiple J. M., Simons E. R., Clark R. A. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol. 1983 Jul;97(1):52–61. doi: 10.1083/jcb.97.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dale D. C., Fauci A. S., Wolff S. M. The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infection in patients with Wegener's granulomatosis. Arthritis Rheum. 1973 Sep-Oct;16(5):657–664. doi: 10.1002/art.1780160510. [DOI] [PubMed] [Google Scholar]
  5. Davies D. J., Moran J. E., Niall J. F., Ryan G. B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? 1982 Aug 28-Sep 4Br Med J (Clin Res Ed) 285(6342):606–606. doi: 10.1136/bmj.285.6342.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DeRemee R. A., McDonald T. J., Weiland L. H. Wegener's granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc. 1985 Jan;60(1):27–32. doi: 10.1016/s0025-6196(12)65279-3. [DOI] [PubMed] [Google Scholar]
  7. Donald K. J., Edwards R. L., McEvoy J. D. An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis. Pathology. 1976 Apr;8(2):161–169. doi: 10.3109/00313027609094443. [DOI] [PubMed] [Google Scholar]
  8. Elkon K. B., Sutherland D. C., Rees A. J., Hughes G. R., Batchelor J. R. HLA antigen frequencies in systemic vasculitis: increase in HLA-DR2 in Wegener's granulomatosis. Arthritis Rheum. 1983 Jan;26(1):102–105. doi: 10.1002/art.1780260118. [DOI] [PubMed] [Google Scholar]
  9. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988 Jun 23;318(25):1651–1657. doi: 10.1056/NEJM198806233182504. [DOI] [PubMed] [Google Scholar]
  10. Fauci A. S., Haynes B., Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med. 1978 Nov;89(5 Pt 1):660–676. doi: 10.7326/0003-4819-89-5-660. [DOI] [PubMed] [Google Scholar]
  11. Gephardt G. N., Ahmad M., Tubbs R. R. Pulmonary vasculitis (Wegener's granulomatosis). Immunohistochemical study of T and B cell markers. Am J Med. 1983 Apr;74(4):700–704. doi: 10.1016/0002-9343(83)91030-6. [DOI] [PubMed] [Google Scholar]
  12. Germuth F. G., Jr, Pollack A. D. Immune complex disease. 3. The granulomatous manifestations. Johns Hopkins Med J. 1967 Oct;121(4):254–262. [PubMed] [Google Scholar]
  13. Israel H. L. Sulfamethoxazole-trimethoprim therapy for Wegener's granulomatosis. Arch Intern Med. 1988 Oct;148(10):2293–2295. [PubMed] [Google Scholar]
  14. Joller-Jemelka H. I., Grob P. J. Wegenersche Granulomatose und Autoantikörper gegen Zytoplasmagranula von Neutrophilen. Schweiz Med Wochenschr. 1988 Aug 20;118(33):1163–1168. [PubMed] [Google Scholar]
  15. Kao R. C., Wehner N. G., Skubitz K. M., Gray B. H., Hoidal J. R. Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest. 1988 Dec;82(6):1963–1973. doi: 10.1172/JCI113816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Katz P., Alling D. W., Haynes B. F., Fauci A. S. Association of Wegener's granulomatosis with HLA-B8. Clin Immunol Immunopathol. 1979 Oct;14(2):268–270. doi: 10.1016/0090-1229(79)90150-8. [DOI] [PubMed] [Google Scholar]
  17. Lie J. T. Classification and immunodiagnosis of vasculitis: a new solution or promises unfulfilled? J Rheumatol. 1988;15(5):728–732. [PubMed] [Google Scholar]
  18. Lockwood C. M., Bakes D., Jones S., Whitaker K. B., Moss D. W., Savage C. O. Association of alkaline phosphatase with an autoantigen recognised by circulating anti-neutrophil antibodies in systemic vasculitis. Lancet. 1987 Mar 28;1(8535):716–720. doi: 10.1016/s0140-6736(87)90357-6. [DOI] [PubMed] [Google Scholar]
  19. Lüdemann G., Gross W. L. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. Clin Exp Immunol. 1987 Aug;69(2):350–357. [PMC free article] [PubMed] [Google Scholar]
  20. Lüdemann J., Utecht B., Gross W. L. Detection and quantitation of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis by ELISA using affinity-purified antigen. J Immunol Methods. 1988 Nov 10;114(1-2):167–174. doi: 10.1016/0022-1759(88)90169-x. [DOI] [PubMed] [Google Scholar]
  21. Parlevliet K. J., Henzen-Logmans S. C., Oe P. L., Bronsveld W., Balm A. J., Donker A. J. Antibodies to components of neutrophil cytoplasm: a new diagnostic tool in patients with Wegener's granulomatosis and systemic vasculitis. Q J Med. 1988 Jan;66(249):55–63. [PubMed] [Google Scholar]
  22. Pinching A. J., Rees A. J., Pussell B. A., Lockwood C. M., Mitchison R. S., Peters D. K. Relapses in Wegener's granulomatosis: the role of infection. Br Med J. 1980 Sep 27;281(6244):836–838. doi: 10.1136/bmj.281.6244.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rasmussen N., Lüdemann J., Utecht B. ELISA examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA. APMIS Suppl. 1989;6:21–22. [PubMed] [Google Scholar]
  24. Rasmussen N., Petersen J., Ralfkiaer E., Avnstøm S., Wiik A. Spontaneous and induced immunoglobulin synthesis and anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: relation to leukocyte subpopulations in blood and active lesions. Rheumatol Int. 1988;8(4):153–158. doi: 10.1007/BF00270453. [DOI] [PubMed] [Google Scholar]
  25. Ronco P., Verroust P., Mignon F., Kourilsky O., Vanhille P., Meyrier A., Mery J. P., Morel-Maroger L. Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies. Q J Med. 1983 Spring;52(206):212–223. [PubMed] [Google Scholar]
  26. Savage C. O., Winearls C. G., Jones S., Marshall P. D., Lockwood C. M. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet. 1987 Jun 20;1(8547):1389–1393. doi: 10.1016/s0140-6736(87)90591-5. [DOI] [PubMed] [Google Scholar]
  27. Shillitoe E. J., Lehner T., Lessof M. H., Harrison D. F. Immunological features of Wegener's granulomatosis. Lancet. 1974 Feb 23;1(7852):281–284. doi: 10.1016/s0140-6736(74)92594-x. [DOI] [PubMed] [Google Scholar]
  28. Specks U., Wheatley C. L., McDonald T. J., Rohrbach M. S., DeRemee R. A. Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc. 1989 Jan;64(1):28–36. doi: 10.1016/s0025-6196(12)65300-2. [DOI] [PubMed] [Google Scholar]
  29. West B. C., Todd J. R., King J. W. Wegener granulomatosis and trimethoprim-sulfamethoxazole. Complete remission after a twenty-year course. Ann Intern Med. 1987 Jun;106(6):840–842. doi: 10.7326/0003-4819-106-6-840. [DOI] [PubMed] [Google Scholar]
  30. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl. 1989;6:12–13. [PubMed] [Google Scholar]
  31. Wiik A., Jensen E., Friis J. Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis. 1974 Nov;33(6):515–522. doi: 10.1136/ard.33.6.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yuasa K., Tokitsu M., Goto H., Kato H., Shimada K. Wegener's granulomatosis: diagnosis by transbronchial lung biopsy, evaluation by gallium scintigraphy and treatment with sulfamethoxazole/trimethoprim. Am J Med. 1988 Feb;84(2):371–372. doi: 10.1016/0002-9343(88)90450-0. [DOI] [PubMed] [Google Scholar]
  33. van der Woude F. J., Arisz L., Meijer S., Donker A. J., Hoedemaeker P. J., van Overbeek J. J. Wegener's granulomatosis. A clinicopathological study in twelve patients. Neth J Med. 1978;21(5):205–220. [PubMed] [Google Scholar]
  34. van der Woude F. J., Hoorntje S. J., Weening J. J., van Overbeek J. J., van der Hem G. K. Renal involvement in Wegener's granulomatosis. Report of three unusual cases. Nephron. 1982;32(2):185–187. doi: 10.1159/000182841. [DOI] [PubMed] [Google Scholar]
  35. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]
  36. vd Wall Bake A. W., Lobatto S., Jonges L., Daha M. R., van Es L. A. IgA antibodies directed against cytoplasmic antigens of polymorphonuclear leukocytes in patients with Henoch-Schoenlein purpura. Adv Exp Med Biol. 1987;216B:1593–1598. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES